Haug Partners Successfully Defends Takeda’s Vyvanse® Patents At Trial Against Generic Challenge READ MORE
Treehouse Avatar LLC v. Valve Corp.: District Court Did Not Abuse Its Discretion in Striking Expert Testimony That Failed to Rely on the Court’s Claim Construction READ MORE
Narrowing the Disclaimer Doctrine: Federal Circuit Cabins the Reach of Disclaimers in the IPR Context READ MORE
Suboxone “Product Hopping” MDL: District Court Finds No Conspiracy Between Sublingual Film Developer and Opioid Treatment Manufacturer READ MORE
Just The Beginning For Patent Waivers? WTO Issues Precedential Decision Sending Shock Waves Throughout the IP World READ MORE
